At a glance
ClinicalIndex Comparison RecordN/ACompleted· 700 enrolled
Drug / intervention
Laryngeal mask insertion (LMA ProSeal) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LMA ProSeal & I-Gel : a Prospective Controlled Trial
In Brief
A clinical study evaluating Laryngeal mask insertion (LMA ProSeal) and Laryngeal mask insertion (I-Gel) for Endotracheal Intubation. Completed, enrolled 700 participants across 1 site.
Detailed Summary
The i-gel is a new supra glottic airway device with a non inflatable cuff and an oesophageal vent. The aim of this study is to compare this device to the LMA ProSeal. The study is approved by the institutional ethic committee. 222 patients will be enrolled in each group. The objectives of the study will be to compare insertion success rate, leak pressure, ventilatory parameters and adverse event rate.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndotracheal Intubation
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2008
Enrollment StartMar 2008
Primary CompletionDec 2013
TodayJul 2026
First PostedFeb 27, 2008
Enrollment StartMar 1, 2008
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 18.3 years ago
Interventions
Laryngeal mask insertion (LMA ProSeal)device
Laryngeal mask insertion
Laryngeal mask insertion (I-Gel)device
Laryngeal mask insertion